Home

Royal Bank of Canada (RY)

130.17
+0.00 (0.00%)
NYSE · Last Trade: Jun 27th, 7:49 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close130.17
Open-
Bid127.10
Ask131.50
Day's RangeN/A - N/A
52 Week Range102.89 - 130.51
Volume0
Market Cap186.23B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield2.052 (1.58%)
1 Month Average Volume1,009,546

Chart

About Royal Bank of Canada (RY)

Royal Bank of Canada is a leading financial services institution that provides a wide range of banking and financial solutions to individuals, businesses, and institutions. The bank offers personal and commercial banking services, wealth management, investment banking, and capital markets services. With a robust network of branch locations and digital platforms, it aims to meet the diverse needs of its clients while focusing on innovation and customer service. Royal Bank of Canada is committed to enhancing the financial well-being of its customers and leveraging its expertise to support economic growth in the communities it serves. Read More

News & Press Releases

Incyte CEO Shake-Up Sparks M&A Buzz As RBC Analyst Highlights Meury’s Track Record: Retail Is All Instocktwits.com
Bill Meury previously led Karuna Therapeutics through a $14 billion sale to Bristol Myers Squibb and steered Anthos Therapeutics ahead of its acquisition by Novartis.
Via Stocktwits · June 27, 2025
CorMedix Stock Tumbles After $85M Stock Sale; But Retail Sees Bargain In DefenCath Betstocktwits.com
The offering follows an upward revision to CorMedix’s Q2 revenue forecast, driven by faster-than-expected rollout of its FDA-approved DefenCath therapy across an extensive dialysis network.
Via Stocktwits · June 27, 2025
Benchmark Hikes Tesla Price Target To $475, Says EV Maker Has Advantages Over Waymo In Robotaxi Segmentstocktwits.com
The new price target represents a 45% upside to the stock’s closing price on Wednesday and follows the EV maker’s successful pilot launch of its robotaxis in Austin over the weekend.
Via Stocktwits · June 26, 2025
Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopesinvestors.com
Bill Meury will take the place of Herve Hoppenot, who is retiring after 11 years at Incyte's helm.
Via Investor's Business Daily · June 26, 2025
Kratos Stock Sinks After $484M Offering Priced Below Market; Retail Traders Shrug Off Dilutionstocktwits.com
The equity raise comes as Kratos expands its role in next-gen defense systems, including a new propulsion partnership with GE Aerospace and growing investor interest driven by bullish analyst coverage.
Via Stocktwits · June 26, 2025
RBC Analyst Sees Growth Potential In TD Synnex Despite Short-Term Margin Pressuresbenzinga.com
RBC Capital Markets analyst David Paige reiterated an Outperform rating on TD Synnex and maintained a $145 price forecast.
Via Benzinga · June 25, 2025
BlackBerry Stock Jumps After Wall Street Hikes Price Targets, But Remains Cautious: Retail’s Exuberantstocktwits.com
Analysts are cautiously optimistic on BlackBerry, citing stronger pipeline visibility with QNX and IoT viewed as key growth drivers after its Q1 earnings beat estimates.
Via Stocktwits · June 25, 2025
3 Skyrocketing Artificial Intelligence (AI) Stocks That Can Plummet 71% to 80%, According to Select Wall Street Analystsfool.com
Today's high-octane AI stocks could be some of the worst performers over the next year, based on the forecasts of select analysts.
Via The Motley Fool · June 25, 2025
3 International Bank Stocks With Strong Dividends
Can international stocks continue to outperform their US counterparts? Structrual trends points to continued strength, and these 3 stocks are poised to profit.
Via MarketBeat · June 24, 2025
Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offeringstocktwits.com
The offering is being led by J.P. Morgan, Morgan Stanley, Guggenheim Securities, and Cantor.
Via Stocktwits · June 23, 2025
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Druginvestors.com
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug.
Via Investor's Business Daily · June 23, 2025
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trialstocktwits.com
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said.
Via Stocktwits · June 23, 2025
CarMax Beat Expectations, But Here's What Could Still Hold It Backbenzinga.com
RBC maintains Outperform rating on CarMax, raises price target to $81. Q1 earnings beat estimates with strong sales growth, market share gains, and cost management efforts.
Via Benzinga · June 23, 2025
Melissa Sanasie Champions Data Literacy and Storytelling in Marketing
Toronto, Ontario - In a world increasingly shaped by fast-moving data and ever-shifting customer expectations, Melissa Sanasie, an accomplished marketing leader with over 12 years of experience, is calling on marketing professionals to sharpen both sides of their craft: data literacy and creative strategy.
Via Get News · June 23, 2025
Cidara Launches 93% As A Universal Flu Shot Becomes A Closer Realityinvestors.com
The midstage study hit all its goals, representing a "best case" scenario, according to one analyst.
Via Investor's Business Daily · June 23, 2025
Circle, GMS Stocks See Big Jump Friday Morning – Here’s What Wall Street Analysts Are Sayingstocktwits.com
While many analysts on Wall Street have raised their price targets on GMS after The Wall Street Journal’s report that Home Depot may have submitted a competing bid against QXO, RBC Capital said the lack of details “raises questions.”
Via Stocktwits · June 20, 2025
$1000 Invested In RBC Bearings 15 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · June 19, 2025
InvestorNewsBreaks – Aegis Capital Corp. Announces Completion of $4.3 Million Public Offering for Stardust Power (NASDAQ: SDST)
Aegis Capital, acting as sole book-running manager, today announced the successful closing of a $4.3 million underwritten public offering for Stardust Power Inc. (NASDAQ: SDST) , an American developer of battery-grade lithium products. The offering included 21,500,000 shares of common stock at a public offering price of $0.20 per share. Stardust Power has also granted Aegis a 45-day option to purchase up to an additional 3,225,000 shares to cover over-allotments, which could bring total gross proceeds to approximately $4.9 million. Proceeds from the offering will fund the completion of the Definitive Feasibility Study (DFS/FEL-3) for the Company’s proposed lithium processing facility in Muskogee, Oklahoma—a critical milestone toward advancing the project to final investment decision and construction of Phase 1.
Via Investor Brand Network · June 18, 2025
Should You Forget Nvidia and Buy This Artificial Intelligence (AI) Stock Right Now?fool.com
Via The Motley Fool · June 17, 2025
Wall Street Turns Bullish On Hinge Health As Analysts Laud Profitable Growth, AI Disruption In MSK Carestocktwits.com
Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance.
Via Stocktwits · June 16, 2025
RBC BEARINGS INC (NYSE:RBC) – A Quality Stock with Strong Fundamentalschartmill.com
RBC Bearings (NYSE:RBC) meets quality investing criteria with strong ROIC, EBIT growth, and profit quality, though its valuation remains high. A deeper look for long-term investors.
Via Chartmill · June 16, 2025
Adobe Stock Slides as AI Optimism Reportedly Fades, But Retail Remains Defiantly Bullishstocktwits.com
Investors are growing cautious about the timeline and payoff of Adobe’s AI initiatives, despite the company beating Q2 estimates and raising its full-year revenue forecast.
Via Stocktwits · June 13, 2025
Air India Crash Prompts Boeing Top Execs, Including CEO Ortberg, To Cancel Paris Air Show Visitstocktwits.com
The Paris Air Show, which begins Monday, is the aviation industry’s largest trade show and typically sees several deals between aircraft manufacturers and airlines.
Via Stocktwits · June 13, 2025
A Glimpse Into The Expert Outlook On RBC Bearings Through 4 Analystsbenzinga.com
Via Benzinga · June 12, 2025
Snowflake Rival Databricks Touts Torrid Revenue Growth Rate Amid AI Boominvestors.com
Snowflake stock has been pressured by views that Databricks is gaining market share as companies develop artificial intelligence applications.
Via Investor's Business Daily · June 12, 2025